Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 25, Issue 1, 2001, Pages 45-50

  Haczku, A ^a   Atochina, E N ^a   Tomer, Y ^a   Chen, H ^a   Scanlon, S T ^a   Russo, S ^a   Xu, J ^a   Panettieri R A , Jr ^a   Beers, M F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ASPERGILLUS FUMIGATUS; FUNGI; MURINAE;

EID: 0034914910     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.25.1.4391     Document Type: Article

References (35)

1. Pulmonary surfactant in health and human lung diseases: State of the art
2. Collectins and pulmonary innate immunity
3. Molecular and cellular processing of lung surfactant
4. Collectins and pulmonary host defense
5. Pulmonary surfactant apoproteins: A review of protein and genomic structure
6. Surfactant and acquired lung diseases
7. Therapeutic strategies for allergic diseases
8. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant: Characterization and biophysical activity
9. Surfactant protein C: A review of its unique properties and metabolism
10. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge
11. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant
12. The role of pulmonary surfactant in obstructive airways disease
13. Interactions of surfactant protein A with pathogens
14. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens
15. Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia
16. Binding of pulmonary sarfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages
17. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE
18. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma
19. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice
20. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice
21. CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness
22. Pneumocystis carinii pneumonia induces selective alterations in component expression and biophysical activity of pulmonary surfactant
23. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice
24. Allergic bronchopulmonary aspergillosis
25. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates
26. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma
27. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS
28. Regulation of surfactant proteins A and B by TNF-α and phorbol ester independent of NF-κB
29. Characterization of rabbit SP-B promoter region responsive to downregulation by TNF-α
30. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs
31. A pilot study of surfactant inhalation for the treatment of asthma attack
32. Regulation of pulmonary surfactant secretion and clearance
33. Cytokines and production of surfactant components
34. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis
35. IL-4 increases surfactant and regulates metabolism in vivo